VMP 38896211000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Gliclazide 30mg modified-release tablets
BNF code 0601021M0AAAMAM
Virtual Therapeutic Moiety Gliclazide
Date identifier became valid 19 Aug 2020
Previous product identifier 134587001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Gliclazide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 30.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Diamicron 30mg MR tablets (Lexon (UK) Ltd)
Diamicron 30mg MR tablets (Servier Laboratories Ltd)
Diamicron 30mg MR tablets (Sigma Pharmaceuticals Plc)
Edicil MR 30mg tablets (Teva UK Ltd)
Gliclazide 30mg modified-release tablets (A A H Pharmaceuticals Ltd)
Gliclazide 30mg modified-release tablets (Accord-UK Ltd)
Gliclazide 30mg modified-release tablets (Krka UK Ltd)
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd)
Ziclaseg 30mg modified-release tablets (Lupin Healthcare (UK) Ltd)
Zicron PR 30mg tablets (Bristol Laboratories Ltd)
Virtual Medicinal Product Packs
Gliclazide 30mg modified-release tablets 112 tablet
Gliclazide 30mg modified-release tablets 28 tablet
Gliclazide 30mg modified-release tablets 30 tablet
Gliclazide 30mg modified-release tablets 56 tablet
Gliclazide 30mg modified-release tablets 60 tablet
Gliclazide 30mg modified-release tablets 84 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback